{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:28:13Z","timestamp":1772166493321,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immediate hypersensitivity reaction to ursodiol is rare and there is no previously published protocol on ursodiol desensitization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 59-year-old woman with primary biliary cholangitis (PBC) developed an immediate hypersensitivity reaction to ursodiol\u2014the first-line treatment for PBC. When she switched to a second-line treatment, her PBC continued to progress. As such, she completed a novel 12-step desensitization protocol to oral ursodiol. She experienced recurrent pruritus after each dose following desensitization, which subsided after a month of being on daily ursodiol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Immediate hypersensitivity reaction to ursodiol is uncommon. Our case demonstrated that this novel desensitization protocol to ursodiol could be safely implemented when alternative options are not available or have proven inferior in efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13223-021-00578-7","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T07:03:04Z","timestamp":1626937384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immediate hypersensitivity reaction followed by successful oral desensitization to ursodiol"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1108-2067","authenticated-orcid":false,"given":"Erika Yue","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"578_CR1","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","volume":"335","author":"MM Kaplan","year":"1996","unstructured":"Kaplan MM. Primary biliary cirrhosis. N Engl J Med. 1996;335:1570\u201380.","journal-title":"N Engl J Med"},{"key":"578_CR2","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1056\/NEJMct074694","volume":"357","author":"K Lindor","year":"2007","unstructured":"Lindor K. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. N Engl J Med. 2007;357:1524\u20139.","journal-title":"N Engl J Med"},{"key":"578_CR3","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/hep.22428","volume":"48","author":"C Corpechot","year":"2008","unstructured":"Corpechot C, Abenavoli L, Rabahi N, Chretien Y, Andreani T, Johanet C, et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology. 2008;48:871\u20137.","journal-title":"Hepatology"},{"key":"578_CR4","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1046\/j.1365-2036.2003.01792.x","volume":"18","author":"W Hempfling","year":"2003","unstructured":"Hempfling W, Dilger K, Beuers U. Systematic review: ursodeoxycholic acid-adverse effects and drug interactions. Aliment Pharmacol Ther. 2003;18:963\u201372.","journal-title":"Aliment Pharmacol Ther"},{"key":"578_CR5","volume-title":"UpToDate","author":"M Castells","year":"2020","unstructured":"Castells M, Solensky R. Rapid drug desensitization for immediate hypersensitivity reactions. In: Post TW, editor. UpToDate. Waltham: UpToDate; 2020."},{"key":"578_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","volume":"17","author":"AF Gulamhusein","year":"2020","unstructured":"Gulamhusein AF, Hirschfield GM. Primary biliary cholangitis: pathogenesis and therapeutic opportunities. Nat Rev Gastroenterol Hepatol. 2020;17:93\u2013110.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"578_CR7","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S2210-7401(12)70015-3","volume":"36","author":"R Poupon","year":"2012","unstructured":"Poupon R. Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action. Clin Res Hepatol Gastroenterol. 2012;36(Suppl 1):S3-12.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"578_CR8","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","volume":"147","author":"WJ Lammers","year":"2014","unstructured":"Lammers WJ, van Buuren HR, Hirschfield GM, Janssen HL, Ivernizzi P, Mason AL, et al. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. Gastroenterology. 2014;147:1338\u201349.","journal-title":"Gastroenterology"},{"key":"578_CR9","doi-asserted-by":"publisher","first-page":"S391","DOI":"10.14309\/00000434-201510001-00908","volume":"110","author":"J Phemister","year":"2015","unstructured":"Phemister J, Pourmorteza M, Brahmbhatt P, Reddy C, Young M. Hypersensitivity reaction to ursodiol resulting in cardiac arrhythmia. Am J Gastroenterol. 2015;110:S391.","journal-title":"Am J Gastroenterol"},{"key":"578_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1053\/gast.2001.26929","volume":"121","author":"Y Horiuchi","year":"2001","unstructured":"Horiuchi Y. Lichenoid eruptions due to ursodeoxycholic acid administration. Gastroenterology. 2001;121:501\u20132.","journal-title":"Gastroenterology"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-021-00578-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-021-00578-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-021-00578-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T07:10:57Z","timestamp":1626937857000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/s13223-021-00578-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["578"],"URL":"https:\/\/doi.org\/10.1186\/s13223-021-00578-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-459540\/v1","asserted-by":"object"}]},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]},"assertion":[{"value":"23 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patient consent was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}